<?xml version='1.0' encoding='utf-8'?>
<document id="16273607"><sentence text="Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity."><entity charOffset="32-52" id="DDI-PubMed.16273607.s1.e0" text="carbon tetrachloride" /></sentence><sentence text="To investigate the precise roles of CAR in CCl(4)-induced acute hepatotoxicity" /><sentence text="" /><sentence text="To prepare an acute liver injury model, CCl(4) was intraperitoneally injected in CAR+/+ and CAR-/- mice" /><sentence text="" /><sentence text="Elevation of serum alanine aminotransferase and extension of centrilobular necrosis were slightly inhibited in CAR-/- mice compared to CAR+/+ mice without PB"><entity charOffset="19-26" id="DDI-PubMed.16273607.s6.e0" text="alanine" /></sentence><sentence text=" Administration of a CAR inducer, PB, revealed that CCl(4)-induced liver toxicity was partially inhibited in CAR-/- mice compared with CAR+/+ mice"><entity charOffset="135-139" id="DDI-PubMed.16273607.s7.e0" text="CAR+" /></sentence><sentence text=" On the other hand, androstanol, an inverse agonist ligand, inhibited hepatotoxicity in CAR+/+ but not in CAR-/- mice"><entity charOffset="20-31" id="DDI-PubMed.16273607.s8.e0" text="androstanol" /><entity charOffset="88-98" id="DDI-PubMed.16273607.s8.e1" text="CAR+" /><pair ddi="false" e1="DDI-PubMed.16273607.s8.e0" e2="DDI-PubMed.16273607.s8.e0" /><pair ddi="false" e1="DDI-PubMed.16273607.s8.e0" e2="DDI-PubMed.16273607.s8.e1" /></sentence><sentence text=" Thus, CAR activation caused CCl(4) hepatotoxicity while CAR inhibition resulted in partial protection against CCl(4)-induced hepatotoxicity" /><sentence text=" There were no differences in the expression of CYP2E1, the main metabolizing enzyme for CCl(4), between CAR+/+ and CAR-/- mice"><entity charOffset="105-108" id="DDI-PubMed.16273607.s10.e0" text="CAR+" /></sentence><sentence text=" However, the expression of other CCl(4)-metabolizing enzymes, such as CYP2B10 and 3A11, was induced by PB in CAR+/+ but not in CAR-/- mice"><entity charOffset="110-113" id="DDI-PubMed.16273607.s11.e0" text="CAR+" /></sentence><sentence text=" Although the main pathway of CCl(4)-induced acute liver injury is mediated by CYP2E1, CAR modulates its pathway via induction of CYP2B10 and 3A11 in the presence of activator or inhibitor" /><sentence text="" /><sentence text="The nuclear receptor CAR modulates CCl(4)-induced liver injury via induction of CCl(4)-metabolizing enzymes in the presence of an activator" /><sentence text=" Our results suggest that drugs interacting with nuclear receptors such as PB might play critical roles in drug-induced liver injury or drug-drug interaction even though such drugs themselves are not hepatotoxic" /><sentence text="" /></document>